Fatigue and health-related quality of life in relapsing remitting multiple sclerosis after 2 years glatiramer acetate treatment is predicted by changes at 6 months: an observational multi-centre study

P.J. Jongen, D. Lehnick, J. Koeman, S. Frequin, D. Heersema, B. Kornips, A. Schyns-Soeterboek, L. H. Visser, P. Schiphof, A. Valkenburg, J. Hiel

Research output: Contribution to journalArticleAcademicpeer-review

Original languageAmerican English
JournalJournal of Neurology
Publication statusPublished - 1 Jan 2014

Cite this